Latest News
|
More Articles...
- HUYA Bioscience International® Announces the Successful Completion of Phase 1 Trial of HBI-3000
- Johnson & Johnson Launches Heartline™, the First-of-its-Kind, Virtual Study Designed to Explore if a New iPhone App and Apple Watch Can Help Reduce the Risk of Stroke
- Large Real-World Data Confirm Safety and Effectiveness of LIXIANA®▼ (edoxaban) in Routine Clinical Practice for Elderly AF Patients with Comorbidities
- MediLynx Cardiac Monitoring, LLC introduces dedicated remote monitoring services based on its PocketECG® platform to support hospitals in managing COVID-19 patients in accordance with the latest FDA enforcement policy
- Milestone Pharmaceuticals Announces Topline Results from First-of-its-kind Phase 3 NODE-301 Trial of Etripamil for At-home Acute PSVT Treatment
- Mysterious Heart Damage, Not Just Lung Troubles, Befalling COVID-19 Patients
- New FDA Guidance Allows Use of KardiaMobile 6L to Measure QTc in COVID-19 Patients
- MemorialCare Heart & Vascular Institute at Long Beach Medical Center—Only Southern California Site Participating in Atrial Fibrillation Clinical Trial—Enrolls First Successful Patient
- CardioFocus Announces U.S. FDA PMA Supplement Submission for the Breakthrough HeartLight X3 Endoscopic Ablation System
- VitalConnect Announces Launch of Arrhythmia Detection for Cardiac Patient Care
|
|
